• Latest Posts

Genzyme joins the never-ending list of Ablynx’ partners

Alkermes presents its new treatment of Alzheimer’s agitation

Will there be a New Merck-Serono?

Danish biotech Forward Pharma files for $200m IPO

Active Biotech and Teva together in a Phase II clinical trial against Huntington’s disease

ADVERTISEMENT